BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 8438716)

  • 1. Intermittent claudication: From its risk factors to its long-term prognosis in men. The Quebec Cardiovascular Study.
    St-Pierre A; Cantin B; Lamarche B; Auger D; Després J; Dagenais GR
    Can J Cardiol; 2010 Jan; 26(1):17-21. PubMed ID: 20101352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in High-Acuity Cardiovascular Events During the COVID-19 Pandemic.
    Wharam JF; LeCates RF; Thomas A; Zhang F; Argetsinger S; Garabedian LF; Galbraith AA
    JAMA Health Forum; 2024 Jan; 5(1):e234572. PubMed ID: 38180767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of congestive heart failure: the Framingham Heart Study perspective.
    Mahmood SS; Wang TJ
    Glob Heart; 2013 Mar; 8(1):77-82. PubMed ID: 23998000
    [No Abstract]   [Full Text] [Related]  

  • 4. The relation of chronic diseases to all-cause mortality risk--the Seven Countries Study.
    Menotti A; Blackburn H; Seccareccia F; Kromhout D; Nissinen A; Aravanis C; Giampaoli S; Mohacek I; Nedeljkovic S; Toshima H
    Ann Med; 1997 Apr; 29(2):135-41. PubMed ID: 9187228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing various AI approaches to traditional quantitative assessment of the myocardial perfusion in [
    Bors S; Abler D; Dietz M; Andrearczyk V; Fageot J; Nicod-Lalonde M; Schaefer N; DeKemp R; Kamani CH; Prior JO; Depeursinge A
    Sci Rep; 2024 Apr; 14(1):9644. PubMed ID: 38671059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Systolic and Diastolic Blood Pressure Levels and Cardiovascular Mortality in Patients With Type 2 Diabetes-Results From a Large Registry Cohort in Asia.
    Seng LL; Hai Kiat TP; Bee YM; Jafar TH
    J Am Heart Assoc; 2023 Dec; 12(23):e030772. PubMed ID: 37930066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Apical Periodontitis and Chronic Diseases: An Umbrella Review.
    Pinto KP; Serrão G; Alves Ferreira CM; Sassone LM; Fidalgo TKDS; Silva EJNL
    Iran Endod J; 2023; 18(3):134-144. PubMed ID: 37431524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation.
    Nakhlé G; Tardif JC; Roy D; Rivard L; Samuel M; Dubois A; LeLorier J
    Mol Diagn Ther; 2023 May; 27(3):383-394. PubMed ID: 36720803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of asteroid hyalosis and systemic risk factors in United States adults.
    Duong R; Cai X; Ambati N; Shildkrot Y; Sieburth R
    Eye (Lond); 2023 Jun; 37(8):1678-1682. PubMed ID: 36038722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Study.
    Kim KS; Hong S; Han K; Park CY
    J Lipid Atheroscler; 2022 Jan; 11(1):73-83. PubMed ID: 35118023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
    Chen G; Farris MS; Cowling T; Pinto L; Rogoza RM; MacKinnon E; Champsi S; Anderson TJ
    Clin Cardiol; 2021 Nov; 44(11):1613-1620. PubMed ID: 34585767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Long-Term Incidence of Heart Failure and Predictors Following Newly Developed Acute Myocardial Infarction: A 10 Years Retrospective Cohort Study with Korean National Health Insurance Data.
    Choi H; Seo JY; Shin J; Choi BY; Kim YM
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34201267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes.
    Herrett E; George J; Denaxas S; Bhaskaran K; Timmis A; Hemingway H; Smeeth L
    Eur Heart J Acute Cardiovasc Care; 2013 Sep; 2(3):235-45. PubMed ID: 24222835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events.
    Paulmier B; Duet M; Khayat R; Pierquet-Ghazzar N; Laissy JP; Maunoury C; Hugonnet F; Sauvaget E; Trinquart L; Faraggi M
    J Nucl Cardiol; 2008; 15(2):209-17. PubMed ID: 18371592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost effectiveness of ACE inhibitors as first-line antihypertensive therapy.
    Nordmann AJ; Krahn M; Logan AG; Naglie G; Detsky AS
    Pharmacoeconomics; 2003; 21(8):573-85. PubMed ID: 12751915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necessity of using intermediate outcome to proxy long term effects. The example of thrombolytics.
    Schwartz JS
    Pharmacoeconomics; 1995 Jan; 7(1):7-13. PubMed ID: 10155295
    [No Abstract]   [Full Text] [Related]  

  • 18. Preexisting cardiovascular conditions and long-term prognosis after initial myocardial infarction: the Framingham Study.
    Cupples LA; Gagnon DR; Wong ND; Ostfeld AM; Kannel WB
    Am Heart J; 1993 Mar; 125(3):863-72. PubMed ID: 8438716
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.